{"name": "Acumen Pharmaceuticals",
 "permalink": "acumen-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/acumen-pharmaceuticals",
 "homepage_url": "http://www.acumenpharm.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "1-925-368-8508",
 "description": "",
 "created_at": "Fri Apr 30 04:11:04 UTC 2010",
 "updated_at": "Mon May 27 12:59:59 UTC 2013",
 "overview": "\u003Cp\u003EAcumen Pharmaceuticals is a discovery stage biotechnology company focused on discovering and developing in partnership with leading pharmaceutical companies best in class therapeutics and diagnostics for Alzheimer\u0026#8217;s disease. Acumen owns or has exclusive license to a broad set of patents, related intellectual property and drug development capabilities relating to amyloid beta soluble oligomers, now widely believed to be an underlying cause of Alzheimer\u0026#8217;s disease. Acumen is partnered with Merck \u0026amp; Co. for the development of certain monoclonal antibody therapeutics. NeuroVentures LLC and Biotechnology Value Fund LP have made investments in the company.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       67],
      "assets/images/resized/0008/5429/85429v1-max-150x150.jpg"],
     [[155,
       70],
      "assets/images/resized/0008/5429/85429v1-max-250x250.jpg"],
     [[155,
       70],
      "assets/images/resized/0008/5429/85429v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$2.2M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 1500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 8,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "NeuroVentures",
         "permalink": "neuroventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0006/1657/61657v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0006/1657/61657v1-max-250x250.jpg"],
             [[423,
               59],
              "assets/images/resized/0006/1657/61657v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1576885/000157688513000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 700000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 15,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "4435 North First Street, # 360",
    "address2": "",
    "zip_code": "94551",
    "city": "Livermore",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        124],
       "assets/images/resized/0008/5430/85430v1-max-150x150.jpg"],
      [[250,
        207],
       "assets/images/resized/0008/5430/85430v1-max-250x250.jpg"],
      [[450,
        373],
       "assets/images/resized/0008/5430/85430v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}